Once Commonwealth approval is granted, no additional Victorian approval is required if the medicinal cannabis product is classified as a Schedule 4 medicine. Schedule 4 medicinal cannabis preparations for therapeutic use must contain at least 98% (of total cannabinoids) cannabidiol (CBD) and contain 2% or less of other cannabinoids including tetrahydrocannabinol (THC), the psychoactive component of cannabis.
A Victorian treatment permit under the Drugs, Poisons and Controlled Substances Act, 1981 is required if the doctor intends to prescribe a Schedule 8 medicinal cannabis product, which are generally those medicinal cannabis preparations containing higher proportions of THC. This is a requirement which applies to treatment with any Schedule 8 drug, such as opioids – it is not a special medicinal cannabis requirement. A Victorian treatment permit is also required for Schedule 8 medicinal cannabis product that are registered on the ARTG (in which case no Commonwealth approvals are necessary).
The Victorian Office of Medicinal Cannabis is committed to assessing applications for Schedule 8 permits within one working day of receipt of all necessary documentation.
While we encourage applications to be lodged concurrently with both the Commonwealth and Victoria, the Victorian permit cannot be finalised until the doctor has obtained the necessary Commonwealth approval.